Primary study · included by 1 review
Antihypertensive medications are associated with the risk of kidney and bladder cancer: a systematic review and meta-analysis.
Xie 2020 · Xie Yuxiu, Xu Peng, Wang Meng, et al. · Aging · 2020
Included by
| Outcome this study informs | Pooled effect | Evidence | Certainty |
|---|---|---|---|
Risk of bladder cancer With angiotensin II receptor blockers vs Without angiotensin II receptor blockers | RR 1.07 [1.03, 1.11] | 5 studies · 1547916 participants | Low |
Risk of bladder cancer With metformin vs Without metformin | OR 0.76 [0.63, 0.91] | 3 studies · 465588 participants | Very low |
Risk of bladder cancer With angiotensin-converting enzyme inhibitors vs Without angiotensin-converting enzyme inhibitors | RR 1.04 [1.00, 1.08] | 4 studies · 2560819 participants | Very low |
Risk of bladder cancer With estrogen-progestogen therapy for hormone replacement therapy vs Without estrogen-progestogen therapy for hormone replacement therapy | RR 0.79 [0.59, 1.06] | 5 studies | Very low |
Risk of bladder cancer With calcium channel blockers vs Without calcium channel blockers | RR 1.16 [0.91, 1.47] | 6 studies · 1097423 participants | Very low |
Risk of bladder cancer With diuretics vs Without diuretics | RR 1.16 [0.93, 1.46] | 2 studies · 67504 participants | Very low |
1 including review in total.